Jan 11, 2023 / 12:30AM GMT
Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst
Hi, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team with JPMorgan. Today, I have Norman Schwartz from the Bio-Rad team. This session will be 40 minutes. We'll start off with the standard 20 minutes of management's presentation, followed by 20 minutes of Q&A.
If you're listening to this via the webcast, feel free to submit a question online through the portal. Otherwise, if you're in person, raise your hand, and we have mic runners throughout the room that can get you a microphone. Norman? Thank you.
Norman D. Schwartz - Bio-Rad Laboratories, Inc. - Chairman, CEO & President
Okay. Great. Thank you. Okay. Well, thank you all for joining us here today. It does feel great to be back here in person after several years in 3 dimensions. Since it has been a few years, I thought I'd take kind of the first part of this to refresh everybody on Bio-Rad and what we've accomplished over the last few years and then show you a little bit about
Bio Rad Laboratories Inc at JPMorgan Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers